Ledger.Open graph →
SEC Form D · filed March 20, 2012

NEUROPHAGE PHARMACEUTICALS INC

Offering
$9.0M
Sold
$9.0M
Exemption
—
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

People & firms on this filing (10)

Hampus Hillerstrom · Cambridge, MAExec · DirectorVicki Sato · Cambridge, MADirectorValerie Calenda · Cambridge, MADirectorPaul Goldenheim · Cambridge, MADirectorJonathan Solomon · Cambridge, MAExec · DirectorMichael Chandler · Goleta, CAExec · DirectorJohn Bowers · Goleta, CADirectorVictoria Katsov · Goleta, CAExec · DirectorEdgar Masri · Goleta, CADirectorGeorge Schmitt · Goleta, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗